BridgeBio Pharma (BBIO)
(Delayed Data from NSDQ)
$25.40 USD
-1.34 (-5.01%)
Updated Sep 23, 2024 04:00 PM ET
After-Market: $25.40 0.00 (0.00%) 6:22 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
11/07/2024
Time: -- |
9/2024 | $-1.02 | 8.07% |
Earnings Summary
For their last quarter, BridgeBio Pharma (BBIO) reported earnings of -$1.02 per share, beating the Zacks Consensus Estimate of $-1.09 per share. This reflects a positive earnings surprise of 6.42%. Look out for BBIO's next earnings release expected on November 07, 2024. For the next earning release, we expect the company to report earnings of -$1.02 per share, reflecting a year-over-year increase of 5.56%.
Earnings History
Price & Consensus
Zacks News for BBIO
Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
BBIO: What are Zacks experts saying now?
Zacks Private Portfolio Services